2005
DOI: 10.1016/j.radonc.2005.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Dose-response in stereotactic irradiation of lung tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
119
0
2

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 228 publications
(128 citation statements)
references
References 28 publications
7
119
0
2
Order By: Relevance
“…A sufficiently long ray is traced from the source position through each target voxel and a raysegment intersection check is performed as depicted in Figure 2a. Depending on whether the ray is inside the segment or not and how close it is to the segment edge, the dose to the target voxel is calculated using Equations (4)(5)(6)(7)(8). The distance between the segment edge and ray is calculated at the isocentre plane as shown in Figure 2b.…”
Section: Dose Calculation To a Moving Targetsupporting
confidence: 53%
See 1 more Smart Citation
“…A sufficiently long ray is traced from the source position through each target voxel and a raysegment intersection check is performed as depicted in Figure 2a. Depending on whether the ray is inside the segment or not and how close it is to the segment edge, the dose to the target voxel is calculated using Equations (4)(5)(6)(7)(8). The distance between the segment edge and ray is calculated at the isocentre plane as shown in Figure 2b.…”
Section: Dose Calculation To a Moving Targetsupporting
confidence: 53%
“…Moreover, hypofractionated treatments have been shown to result in better clinical outcomes for medically inoperable early-stage lung tumours. [4][5][6][7] Better targeting accuracy coupled with superior normal tissue sparing and higher dose conformality, especially with smaller treatment fields used in stereotactic treatments, allows clinicians to prescribe extremely high doses in very few fractions (approximately three). With the advent of image-guided RT, this type of treatment is becoming increasingly common for lung RT.…”
Section: Discussionmentioning
confidence: 99%
“…In a recent review of 18 papers published 1988 Á2000, reporting results with conventional RT, the incidence of local failure of stage I tumours was 40% (6.4 Á70%) [10]. Local failure has been reported up to at least 3 years after RT treatment of stage I NSCLC [29,36,37]. This is similar to our finding with SBRT.…”
Section: Discussionmentioning
confidence: 74%
“…Conventional radiotherapy for early‐stage non‐small cell lung cancer (NSCLC) with or without concurrent chemotherapy is associated with the cancer specific survival rate of below 40% at five years 1 , 2 . Dose escalation and hyprofractional dose delivery have demonstrated an improvement in local control and patients’ survival 3 , 4 . However, the substantial breathing‐induced tumor motion limits their applications.…”
Section: Introductionmentioning
confidence: 99%